Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Medical High Pressure Syringe Market Forecast: What Value Will The Market Reach By 2030?
The medical high pressure syringe market has experienced significant expansion recently. Its value is anticipated to rise from $1.64 billion in 2025 to $1.77 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.1%. The factors contributing to this historical increase include the growing number of CT and MRI scans, the establishment of more diagnostic centers, the demand for precise contrast administration, the standardization of radiology procedures, and advancements in hospital imaging equipment.
The medical high pressure syringe market is anticipated to observe substantial expansion over the upcoming years. It is projected to increase to $2.4 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The expansion during the forecast timeframe is attributable to the proliferation of minimally invasive diagnostics, the broadening of imaging infrastructure, continuous technological advancements in injectors, the demand for more rapid imaging procedures, and an increase in chronic disease diagnostics. Significant developments expected within this period include a growing utilization in advanced diagnostic imaging, the requirement for high-precision contrast delivery, enhanced compatibility with syringeless injectors, a magnified emphasis on patient safety, and the adoption of disposable high-pressure syringes.
Get A Free Sample Report With In-Depth Market Insights:
Medical High Pressure Syringe Market Growth Factors: What’s Supporting Expansion?
The increasing demand for minimally invasive procedures is anticipated to fuel the growth of the medical high pressure syringes market. Minimally invasive procedures are medical techniques employing small incisions or non-invasive methods to carry out surgeries or interventions, resulting in less tissue damage, quicker recovery periods, and reduced postoperative discomfort when compared to traditional surgical approaches. The rise in minimally invasive procedures is driven by patients’ desire for faster recovery and less intrusive treatments, as these typically lead to shorter hospital stays, lower complication risks, and a quicker return to daily activities. Medical high pressure syringes play a vital role in minimally invasive procedures by facilitating the precise and controlled delivery of contrast media, which is crucial for enhancing imaging accuracy during such interventions. For instance, in February 2024, the American Academy of Facial Plastic and Reconstructive Surgery, a US-based non-profit organization, reported that approximately 83% of all medical procedures performed in 2023 were minimally invasive, with standard surgical procedures accounting for the remaining 17%. Consequently, the escalating demand for minimally invasive procedures is a key factor driving the expansion of the medical high pressure syringes market.
Medical High Pressure Syringe Market Segment Analysis: What Are The Core Market Categories?
The medical high pressure syringe market covered in this report is segmented –
1) By Product Type: CT Injector Systems, MRI Injector Systems, Angiographic Injector Systems
2) By Material: Plastic Syringes, Glass Syringes, Metal Syringe
3) By Application: Cardiology, Radiology, Diagnostic Imaging Procedures, Interventional Imaging Procedures
4) By End User: Hospitals, Diagnostic Centers, Ambulatory Surgical Centers
Subsegments:
1) By CT Injector Systems: Single-head CT Injectors, Dual-head CT Injectors, Syringeless Injectors,
2) By MRI Injector Systems: MR-Compatible Injectors, Non-Ferromagnetic Injectors, Syringeless MRI Injectors
3) By Angiographic Injector Systems: Fixed Angiographic Injectors, Mobile Angiographic Injectors, Dual-syringe Injectors
Medical High Pressure Syringe Market Industry Trends: What’s Reshaping Demand?
Companies operating within the medical high pressure syringe market are concentrating on creating advanced technologies, like needle-free solutions, to boost patient safety and optimize injection effectiveness. Needle-free technology involves a technique for administering medications or fluids without the need for conventional needles, with the goal of decreasing discomfort, lowering the chance of infection, and improving patient adherence. As an illustration, in November 2024, Sol-Millennium Medical Group, a US-based Medical Group, introduced its Revolutionary Needle-Free Injection Device for Insulin Administration in Canada, which was specifically engineered for the delivery of insulin. This cutting-edge technology seeks to improve patient comfort and compliance by removing the pain and apprehension often linked with conventional needles. The device utilizes high-pressure technology to administer insulin through the skin without piercing it. Its introduction signifies a notable progression in diabetes treatment, providing a more accessible option for individuals who rely on insulin. This action also indicates Sol-Millennium Medical Group’s strategic foray into the Canadian medical device market.
Medical High Pressure Syringe Market Competitive Landscape: Who Leads The Industry?
Major companies operating in the medical high pressure syringe market are Cardinal Health Inc., Bayer AG, Medline Industries Inc., Becton Dickinson and Company, GE Healthcare Technologies Inc., Terumo Corporation, Gerresheimer AG, Merit Medical Systems Inc., MedNet GmbH, B. Braun Melsungen AG, Ulrich GmbH & Co. KG, Hawkmed (Shenzhen Hawk Medical Instrument Co. Ltd.), Kemper Medical Inc., Smiths Medical (ICU Medical Inc.), APOLLO RT Co. Ltd., Hindustan Syringes & Medical Devices Limited, Guerbet Group, Bracco Imaging S.p.A., Nemoto Kyorindo Co. Ltd., Medrad (Bayer Radiology), AngioDynamics Inc., Shenzhen Antmed Co. Ltd.
View The Full Medical High Pressure Syringe Market Report:
Medical High Pressure Syringe Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the medical high pressure Syringe market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical high pressure syringe market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
